FDA approves sotorasib with panitumumab for colorectal cancer

On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.

Read the full article here

Source: www.fda.gov

Categories: Hem/Oncs, General Medicine News

Tags: ColorectalCancer,KRASG12C,SotoRASib

Tweets with this article

Pashtoon Kasi MD, MS

👇🏽One more option for our patients with #ColorectalCancer. While some drugs are for all, other advances are where tumors harbor the target🎯. More like lock and key. 🔐 💡Continuum of care improving survival📈. #KRASG12C⛔️#SotoRASib💊 @OncoAlert 🔗 https://t.co/EzDqXpzwmZ https://t.co/muqKJpFtHA

Over 18 000 doctors urge Senate to reject Robert F Kennedy Jr as health secretary

More than 18 000 US doctors have signed a letter calling on the Senate to reject Robert F Kennedy Jr as the federal secretary of…

Ash Paul January 17, 2025

FDA Roundup: January 17, 2025

U.S. FDA January 17, 2025

Fellow – American Society for Radiation Oncology (ASTRO) – American Society for Radiation Oncology (ASTRO)

The ASTRO Fellow designation (FASTRO) is awarded based on length of ASTRO membership and commendable service to ASTRO and to the field of radiation oncology.

Fumiko Ladd Chino, MD January 17, 2025

What Clinicians Want to Know: Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer — Friday, January 24, 2025, San Francisco | Research To Practice

Friday, January 24, 2025, San Francisco, California, 6:00 PM – 8:00 PM Pacific Time (9:00 PM – 11:00 PM Eastern Time) Location San Francisco Marriott…

Research To Practice January 17, 2025

Intracytoplasmic inclusions in chronic lymphocytic leukemia cells of an elderly person living with human immunodeficiency virus and presenting with Richter transformation to Hodgkin lymphoma

Click on the article title to read more.

Benlazar S M A January 17, 2025

Meta ends fact-checking, drawing praise from Trump

Meta CEO Mark Zuckerberg ended fact-checking on Facebook and Instagram in favor of community notes, calling the recent election a “cultural tipping point” on free…

Nicole Kuderer January 17, 2025

Red#3, RCTs for Boosters, and how to Make America Healthy Again

Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 500+ Peer Reviewed papers,…

Vinay Prasad January 17, 2025

Pete Hegseth’s Secret History

A whistle-blower report and other documents suggest that Trump’s nominee to run the Pentagon was forced out of previous leadership positions for financial mismanagement, sexist…

Nicole Kuderer January 17, 2025

Impact of Time from Diagnosis to Treatment on Outcomes of Adults with AML Treated with HMA and Venetoclax: A US-Based, Multi-Center, Real-World, Retrospective Analysis from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Disclosures. Guru Murthy:Syndax: Other: Advisory Board; Autolus: Other: Advisory board; Pfizer: Other: Advisory board; BMS: Other: Advisory Board; Amgen: C

Aaron Goodman - “Papa Heme” January 17, 2025

Join the VA Long Beach Healthcare System | VA Long Beach Healthcare System | Physician Jobs | PracticeMatch.com | 1023066

Join the VA Long Beach Healthcare System ID:1023066 – Hematology/Oncology job opportunity in Long Beach CA

Drew Moghanaki January 17, 2025

Related Articles